Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Eur J Cardiothorac Surg. 2020 Oct 1;58(4):752-762. doi: 10.1093/ejcts/ezaa284.
There is widespread acknowledgement that coronavirus disease 2019 (COVID-19) has disrupted surgical services. The European Society of Thoracic Surgeons (ESTS) sent out a survey to assess what impact the COVID-19 pandemic has had on the practice of thoracic oncology surgery.
All ESTS members were invited (13-20 April 2020) to complete an online questionnaire of 26 questions, designed by the ESTS learning affairs committee.
The response rate was 23.0% and the completeness rate was 91.2%. The number of treated COVID-positive cases per hospital varied from fewer than 20 cases (30.6%) to more than 200 cases (22.7%) per hospital. Most hospitals (89.1%) postponed surgical procedures. All hospitals performed patient screening with a nasopharyngeal swab, but only 6.7% routinely tested health care workers. A total of 20% of respondents reported that multidisciplinary meetings were completely cancelled and 66%, that multidisciplinary decisions were not different from normal practice. Trends were recognized in prioritizing surgical patients based on age (younger than 70), type of surgery (lobectomy or less), size of tumour (T1-2) and lymph node involvement (N1). Sixty-three percent of respondents reported that surgeons were involved in daily care of COVID-19-positive patients. Fifty-three percent mentioned that full personal protective equipment was available to them when treating a COVID-19-positive patient.
The COVID-19 pandemic has created issues for the safety of health care workers, and surgeons have been forced to change their routine practice. However, there was no consensus about surgical priorities in lung cancer patients, demonstrating the need for the production of specific guidelines.
人们普遍认识到，2019 年冠状病毒病（COVID-19）扰乱了外科服务。欧洲胸外科协会（ESTS）发出了一项调查，以评估 COVID-19 大流行对胸肿瘤外科学实践的影响。
邀请所有 ESTS 成员（2020 年 4 月 13 日至 20 日）完成由 ESTS 学习事务委员会设计的 26 个问题的在线问卷。
回复率为 23.0%，完整率为 91.2%。每家医院治疗的 COVID-19 阳性病例数量从少于 20 例（30.6%）到每家医院超过 200 例（22.7%）不等。大多数医院（89.1%）推迟了手术程序。所有医院都对患者进行了鼻咽拭子筛查，但只有 6.7%的医院常规检测医护人员。20%的受访者报告说，多学科会议已完全取消，66%的受访者表示多学科决策与正常实践没有区别。根据年龄（小于 70 岁）、手术类型（肺叶切除术或更少）、肿瘤大小（T1-2）和淋巴结受累（N1），确定了优先考虑外科患者的趋势。63%的受访者报告说，外科医生参与了 COVID-19 阳性患者的日常护理。53%的受访者提到，在治疗 COVID-19 阳性患者时，他们有全套的个人防护设备。
COVID-19 大流行给医护人员的安全带来了问题，外科医生被迫改变常规做法。然而，对于肺癌患者的手术优先事项没有共识，这表明需要制定具体的指南。
